The groundbreaking success of Viagra undeniably revolutionized the pharmaceutical landscape, but betting in companies primarily reliant on off-patent versions presents a uncertain picture. Despite early returns were substantial, the expiration of patents and the emergence of less expensive alternatives have weakened market share. Thus, a thorough a